Journal of Clinical Immunology

, Volume 23, Issue 5, pp 317–332 | Cite as

Receptor-Mediated Choreography of Life and Death

Article

Abstract

The cytokine tumor necrosis factor was originally identified as a protein that kills tumor cells. So far, 18 distinct members of this family have been identified. All of them regulate cell survival, proliferation, differentiation, and cell death, also called apoptosis. The apoptosis induced by TNF, and other members of the family, for example, FasL, VEGI, and TRAIL is mediated through death receptors. The apoptotic signals by these cytokines are transduced by eight different death domain- (DD) containing receptors (TNFR1, also called DR1; Fas, also called DR2; DR3, DR4, DR5, DR6, NGFR, and EDAR). The intracellular portion of all these receptors contains a region approximately 80 amino acids long referred to as the “death domain.” Upon activation by its ligand, the DD recruits various proteins that mediate both death and proliferation of the cells. These proteins in turn recruit other proteins via their DDs or death effector domains. The actual destruction of the cell, however, is accomplished by serial activation of a family of proteases referred to as caspases. Cell death is negatively regulated by a family of proteins that includes decoy receptors, silencer of DD, sentrin, cellular FLICE inhibitory protein, cellular inhibitors of apoptosis, and survivin. This review is an attempt to describe how these negative and positive players of cell death perform a harmonious dance with each other.

apoptosis death receptors TNF caspases 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801–809, 1995Google Scholar
  2. 2.
    Prasad KV, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF: CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 94: 6346–6351, 1997Google Scholar
  3. 3.
    Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM, Hood L: MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc Natl Acad Sci USA 94: 11333–11338, 1997Google Scholar
  4. 4.
    Takayama S, Kochel K, Irie S, Inazawa J, Abe T, Sato T, Druck T, Huebner K, Reed JC: Cloning of cDNAs encoding the human BAG1 protein and localization of the human BAG1 gene to chromosome 9p12. Genomics 35: 494–498, 1996Google Scholar
  5. 5.
    Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1–and TNF receptor-induced cell death. Cell 85: 803–815, 1996Google Scholar
  6. 6.
    Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257, 1972Google Scholar
  7. 7.
    Darnay BG, Aggarwal BB: Early events in TNF signaling: A story of associations and dissociations. J Leukoc Biol 61: 559–566, 1997Google Scholar
  8. 8.
    Wallach D, Kovalenko AV, Varfolomeev EE, Boldin MP: Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict. Curr Opin Immunol 10: 279–288, 1998Google Scholar
  9. 9.
    Karin M, Lin A: NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221–227, 2002Google Scholar
  10. 10.
    Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86: 147–157, 1996Google Scholar
  11. 11.
    Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489, 1997Google Scholar
  12. 12.
    Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305, 1989Google Scholar
  13. 13.
    Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267: 10709–10715, 1992Google Scholar
  14. 14.
    Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687–12690, 1996Google Scholar
  15. 15.
    Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard ADs, Bauer KD, Ashkenazi A: Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 6: 1669–1676, 1996Google Scholar
  16. 16.
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Mundy NA, Raju SM, Smulson ME, Yamin T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43, 1995Google Scholar
  17. 17.
    Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, Rouhani FN, Miskinis D, Levine SJ: Identification of ARTS-1 as a novel TNFR1–binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 110: 515–526, 2002Google Scholar
  18. 18.
    Hsu H, Solovyev I, Colombero A, Elliott R, Kelley M, Boyle WJ: ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem 272: 13471–13474, 1997Google Scholar
  19. 19.
    Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM: Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315: 340–343, 1985Google Scholar
  20. 20.
    Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 5214–5218, 1986Google Scholar
  21. 21.
    Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, McCabe S, Qiu WR, Kornuc M, Xia XZ, Guo J, Stolina M, Boyle WJ, Sarosi I, Hsu H, Senaldi G, Theill LE: APRIL and TALL-I and receptors BCMA and TACI: System for regulating humoral immunity. Nat Immunol 1: 252–256, 2000Google Scholar
  22. 22.
    Hatzoglou A, Roussel J, Bourgeade MF, Rogier E, Madry C, Inoue J, Devergne O, Tsapis A: TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 165: 1322–1330, 2000Google Scholar
  23. 23.
    Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C: BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108–2111, 2001Google Scholar
  24. 24.
    Sato T, Irie S, Reed JC: A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett 358: 113–118, 1995Google Scholar
  25. 25.
    Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579–5588, 1995Google Scholar
  26. 26.
    Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3–like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827, 1996Google Scholar
  27. 27.
    Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D: CASH, a novel caspase homologue with death effector domains. J Biol Chem 272:19641–19644, 1997Google Scholar
  28. 28.
    Salvesen GS, Dixit VM: Caspases: Intracellular signaling by proteolysis. Cell 91: 443–446, 1997Google Scholar
  29. 29.
    Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93: 7464–7469, 1996Google Scholar
  30. 30.
    Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501–509, 1998Google Scholar
  31. 31.
    Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98–103, 2000Google Scholar
  32. 32.
    Humke EW, Ni J, Dixit VM: ERICE, a novel FLICE-activatable caspase. J Biol Chem 273: 15702–15707, 1998Google Scholar
  33. 33.
    Eckhart L, Declercq W, Ban J, Rendl M, Lengauer B, Mayer C, Lippens S, Vandenabeele P, Tschachler E: Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 115: 1148–1151, 2000Google Scholar
  34. 34.
    Shu HB, Halpin DR, Goeddel DV: Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 6: 751–763, 1997Google Scholar
  35. 35.
    Camerini D, Walz G, Loenen WA, Borst J, Seed B: The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 147: 3165–3169, 1991Google Scholar
  36. 36.
    Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68: 421–427, 1992Google Scholar
  37. 37.
    Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403–1410, 1989Google Scholar
  38. 38.
    Shu HB, Takeuchi M, Goeddel DV: The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 93: 13973–13978, 1996Google Scholar
  39. 39.
    Inohara N, Koseki T, Hu Y, Chen S, Nunez G: CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci USA 94: 10717–10722, 1997Google Scholar
  40. 40.
    Lippke JA, Gu Y, Sarnecki C, Caron PR, Su MS: Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J Biol Chem 271: 1825–1828, 1996Google Scholar
  41. 41.
    Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761–30764, 1994Google Scholar
  42. 42.
    Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 57: 615–619, 1997Google Scholar
  43. 43.
    Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267: 1494–1498, 1995Google Scholar
  44. 44.
    Kissil JL, Cohen O, Raveh T, Kimchi A: Structure—function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha-and Fas-induced cell death. EMBO J 18: 353–362, 1999Google Scholar
  45. 45.
    Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067–1076, 1997Google Scholar
  46. 46.
    Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818–821, 1997Google Scholar
  47. 47.
    Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A: A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7: 1003–1006, 1997Google Scholar
  48. 48.
    Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699–703, 1998Google Scholar
  49. 49.
    Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990–992, 1996Google Scholar
  50. 50.
    Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM: The receptor for the cytotoxic ligand TRAIL. Science 276: 111–113, 1997Google Scholar
  51. 51.
    Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J: TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7: 831–836, 1997Google Scholar
  52. 52.
    MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES: Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272: 25417–25420, 1997Google Scholar
  53. 53.
    Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L: Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821–830, 1997Google Scholar
  54. 54.
    Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM: Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431: 351–356, 1998Google Scholar
  55. 55.
    Liu J, Na S, Glasebrook A, Fox N, Solenberg PJ, Zhang Q, Song HY, Yang DD: Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6–deficient mice. Immunity 15: 23–34, 2001Google Scholar
  56. 56.
    Zhao H, Yan M, Wang H, Erickson S, Grewal IS, Dixit VM: Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6–deficient mice. J Exp Med 194: 1441–1448, 2001Google Scholar
  57. 57.
    Monreal AW, Zonana J, Ferguson B: Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations. Am J Hum Genet 63: 380–389, 1998Google Scholar
  58. 58.
    Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512, 1995Google Scholar
  59. 59.
    Chu K, Niu X, Williams LT: A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci USA 92: 11894–11898, 1995Google Scholar
  60. 60.
    Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Kronke M: FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937–947, 1996Google Scholar
  61. 61.
    Irie S, Li Y, Kanki H, Ohyama T, Deaven LL, Somlo S, Sato TA: Identification of two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells. DNA Seq 11: 519–526, 2001Google Scholar
  62. 62.
    Sato T, Irie S, Kitada S, Reed JC: FAP-1; A protein tyrosine phosphatase that associates with Fas. Science 268: 411–415, 1995Google Scholar
  63. 63.
    Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747–1756, 1989Google Scholar
  64. 64.
    Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243, 1991Google Scholar
  65. 65.
    Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y, Fernandes-Alnemri T, Croce CM, Litwack G, Tomaselli KJ, Armstrong RC, Alnemri ES: FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1–induced apoptosis. J Biol Chem 272: 18542–18545, 1997Google Scholar
  66. 66.
    Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K, Yonehara S: The CED-4–homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398: 777–785, 1999Google Scholar
  67. 67.
    Vincenz C, Dixit VM: Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95–and p55–mediated death signaling. J Biol Chem 272: 6578–6583, 1997Google Scholar
  68. 68.
    Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195, 1997Google Scholar
  69. 69.
    Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, Scheurich P, Tschopp J, Wajant H: TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29: 1785–1792, 1999Google Scholar
  70. 70.
    Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC: A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15: 837–846, 2001Google Scholar
  71. 71.
    Gurney AL, Marsters SA, Huang RM, Pitti RM, Mark DT, Baldwin DT, Gray AM, Dowd AD, Brush AD, Heldens AD, Schow AD, Goddard AD, Wood WI, Baker KP, Godowski PJ, Ashkenazi A: Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol 9: 215–218, 1999Google Scholar
  72. 72.
    Montgomery RI, Warner MS, Lum BJ, Spear PG: Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427–436, 1996Google Scholar
  73. 73.
    Zhou Z, Kim S, Hurtado J, Lee ZH, Kim KK, Pollok KE, Kwon BS: Characterization of human homologue of 4–1BB and its ligand. Immunol Lett 45: 67–73, 1995Google Scholar
  74. 74.
    Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY: Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263: 9437–9442, 1988Google Scholar
  75. 75.
    Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He WW, Dixit VM: ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 271: 1621–1625, 1996Google Scholar
  76. 76.
    Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW, Dixit VM: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 271: 16720–16724, 1996Google Scholar
  77. 77.
    Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK, Molineaux SM, Yamin TT, Yu VL, Nicholson DW: Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 270: 15870–15876, 1995Google Scholar
  78. 78.
    Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice/ced-3–related gene, encodes both positive and negative regulators of programmed cell death. Cell 78: 739–750, 1994Google Scholar
  79. 79.
    Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, Bump N, Hackett M, Johnston CG, Li P, et al.: Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 270: 15250–15256, 1995Google Scholar
  80. 80.
    Hu S, Vincenz C, Ni J, Gentz R, Dixit VM: I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1–and CD-95–induced apoptosis. J Biol Chem 272: 17255–17257, 1997Google Scholar
  81. 81.
    Yanagisawa K, Tago K, Hayakawa M, Ohki M, Iwahana H, Tominaga S: A novel splice variant of mouse interleukin-1–receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). Biochem J 370: 159–166, 2003Google Scholar
  82. 82.
    Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389–399, 1995Google Scholar
  83. 83.
    Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI: LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 94: 4615–4619, 1997Google Scholar
  84. 84.
    Mongkolsapaya J, Cowper AE, Xu XN, Morris G, McMichael AJ, Bell JI, Screaton GR: Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): A new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol 160: 3–6, 1998Google Scholar
  85. 85.
    Crowe PD, Van Arsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA: A lymphotoxin-beta-specific receptor. Science 264: 707–710, 1994Google Scholar
  86. 86.
    Schievella AR, Chen JH, Graham JR, Lin LL: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 272: 12069–12075, 1997Google Scholar
  87. 87.
    Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, Banks S, Wang GH, Senkevich TG, Alnemri ES, Moss B, Lenardo MJ, Tomaselli KJ, Cohen JI: Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1–induced apoptosis. Proc Natl Acad Sci USA 94:1172–1176, 1997Google Scholar
  88. 88.
    Hu S, Vincenz C, Buller M, Dixit VM: A novel family of viral death effector domain-containing molecules that inhibit both CD-95–and tumor necrosis factor receptor-1–induced apoptosis. J Biol Chem 272: 9621–9624, 1997Google Scholar
  89. 89.
    Fernandes-Alnemri T, Litwack G, Alnemri ES: Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 55: 2737–2742, 1995Google Scholar
  90. 90.
    Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G: Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55: 6045–6052, 1995Google Scholar
  91. 91.
    Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, and Alnemri ES: Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 93: 14486–14491, 1996Google Scholar
  92. 92.
    Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES: The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 271: 27099–27106, 1996Google Scholar
  93. 93.
    Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795–7798, 1995Google Scholar
  94. 94.
    Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M: Expression and structure of the human NGF receptor. Cell 47: 545–554, 1986Google Scholar
  95. 95.
    Truneh A, Sharma S, Silverman C, Khandekar S, Reddy MP, Deen KC, McLaughlin MM, Srinivasula SM, Livi GP, Marshall LA, Alnemri ES, Williams WV, Doyle ML: Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J Biol Chem 275: 23319–23325, 2000Google Scholar
  96. 96.
    Mallett S, Fossum S, Barclay AN: Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—A molecule related to nerve growth factor receptor. EMBO J 9: 1063–1068, 1990Google Scholar
  97. 97.
    Tanikawa C, Matsuda K, Fukuda S, Nakamura Y, Arakawa H: p53RDL1 regulates p53–dependent apoptosis. Nat Cell Biol 5: 216–223, 2003Google Scholar
  98. 98.
    Frankowski H, Castro-Obregon S, del Rio G, Rao RV, Bredesen DE: PLAIDD, a type II death domain protein that interacts with p75 neurotrophin receptor. Neuromol Med 1: 153–170, 2002Google Scholar
  99. 99.
    Duan H, Dixit VM: RAIDD is a new ‘death’ adaptor molecule. Nature 385: 86–89, 1997Google Scholar
  100. 100.
    Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175–179, 1997Google Scholar
  101. 101.
    Sica GL, Zhu G, Tamada K, Liu D, Ni J, Chen L: RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-kappaB. Blood 97: 2702–2707, 2001Google Scholar
  102. 102.
    Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513–523, 1995Google Scholar
  103. 103.
    Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET: Protection against Fas/APO-1–and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 157: 4277–4281, 1996Google Scholar
  104. 104.
    Jiang Y, Woronicz JD, Liu W, Goeddel DV: Related articles, links abstract prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283(5401):543–546, 1999Google Scholar
  105. 105.
    Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe S, Elliott R, Miner K, Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H: TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 192: 137–143, 2000Google Scholar
  106. 106.
    Yan M, Wang LC, Hymowitz SG, Schilbach S, Lee J, Goddard A, de Vos AM, Gao WQ, Dixit VM: Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290: 523–527, 2000Google Scholar
  107. 107.
    Cheng G, Baltimore D: TANK, a co-inducer with TRAF2 of TNF-and CD 40L-mediated NF-kappaB activation. Genes Dev 10: 963–973, 1996Google Scholar
  108. 108.
    Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312: 724–729, 1984Google Scholar
  109. 109.
    Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61: 351–359, 1990Google Scholar
  110. 110.
    Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361–370, 1990Google Scholar
  111. 111.
    Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019–1023, 1990Google Scholar
  112. 112.
    Kwon BS, Tan KB, Ni J, Oh KO, Lee ZH, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TG, Truneh A, Young PR: A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 272: 14272–14276, 1997Google Scholar
  113. 113.
    Hsu H, Xiong J, Goeddel DV: The TNF receptor 1–associated protein TRADD signals cell death and NF-kappa B activation. Cell 81: 495–504, 1995Google Scholar
  114. 114.
    Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with cytoplasmic domain of the 75 kDA tumor necrosis factor receptor. Cell 78: 681–692, 1994Google Scholar
  115. 115.
    Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2–mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269: 1424–1427, 1995Google Scholar
  116. 116.
    Bieche I, Tomasetto C, Regnier CH, Moog-Lutz C, Rio MC, Lidereau R: Two distinct amplified regions at 17q11–q21 involved in human primary breast cancer. Cancer Res 56: 3886–3890, 1996Google Scholar
  117. 117.
    Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J: TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93: 9437–9442, 1996Google Scholar
  118. 118.
    Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue J: Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271: 28745–28748, 1996Google Scholar
  119. 119.
    Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF6 is a signal transducer for interleukin-1. Nature 383: 443–446, 1996Google Scholar
  120. 120.
    Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT: TRAIL-R2; A novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386–5397, 1997Google Scholar
  121. 121.
    Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA: Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186: 1165–1170, 1997Google Scholar
  122. 122.
    Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG: The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813–820, 1997Google Scholar
  123. 123.
    Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6: 79–88, 1997Google Scholar
  124. 124.
    Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS, III, Frankel WN, Lee SY, Choi Y: TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272: 25190–25194, 1997Google Scholar
  125. 125.
    Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ, Bell JI: TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol 7: 693–696, 1997Google Scholar
  126. 126.
    Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815–818, 1997Google Scholar
  127. 127.
    Lee SY, Choi Y: TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)-and CD30–TRAF signaling complexes that inhibits TRAF2–mediated NF-kappaB activation. J Exp Med 185: 1275–1285, 1997Google Scholar
  128. 128.
    Kojima T, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Senba E, Kitamura T: TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with Edar and is expressed in embryonic skin and hair follicles. J Biol Chem 275: 20742–20747, 2000Google Scholar
  129. 129.
    Pan G, Ni J, Yu G, Wei YF, Dixit VM: TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 424: 41–45, 1998Google Scholar
  130. 130.
    Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Herve F, Collard-Dutilleul V, Gu Y, Aldape RA, Lippke JA: A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 14:1914–1922, 1995Google Scholar
  131. 131.
    Faucheu C, Blanchet AM, Collard-Dutilleul V, Lalanne JL, Diu-Hercend A: Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme. Eur J Biochem 236: 207–213, 1996Google Scholar
  132. 132.
    Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM: Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 1: 37–41, 2000Google Scholar
  133. 133.
    Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300–304, 1997Google Scholar
  134. 134.
    Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN: A death-domain-containing receptor that mediates apoptosis. Nature 384: 372–375, 1996Google Scholar
  135. 135.
    Itoh N, Nagata S: A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268: 10932–10937, 1993Google Scholar
  136. 136.
    Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853, 1993Google Scholar
  137. 137.
    Becraft PW, Stinard PS, McCarty DR: CRINKLY4; A TNFR-like receptor kinase involved in maize epidermal differentiation. Science 273(5280):1406–1409, 1996Google Scholar
  138. 138.
    Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87:171, 1996Google Scholar
  139. 139.
    Ellis HM, Horvitz HR: Genetic control of programmed cell death in the nematode C elegans. Cell 44: 817–829, 1986Google Scholar
  140. 140.
    Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43–50, 1998Google Scholar
  141. 141.
    Kawahara A, Enari M, Talanian RV, Wong WW, Nagata S: Fas-induced DNA fragmentation and proteolysis of nuclear proteins. Genes Cells 3: 297–306, 1998Google Scholar
  142. 142.
    Stroh C, Schulze-Osthoff K: Death by a thousand cuts: An ever increasing list of caspase substrates. Cell Death Differ 5: 997–1000, 1998Google Scholar
  143. 143.
    Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387–396, 1996Google Scholar
  144. 144.
    Harper N, Hughes M, MacFarlane M, Cohen GM: FADD and caspase-8 are not recruited to the TNF-R1 signaling complex during TNF-induced apoptosis. J Biol Chem Apr 29, 2003 [epub ahead of print]Google Scholar
  145. 145.
    Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299–308, 1996Google Scholar
  146. 146.
    Grimm S, Stanger BZ, Leder P: RIP and FADD: Two “death domain”-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci USA 93: 10923–10927, 1996Google Scholar
  147. 147.
    Ting AT, Pimentel-Muinos FX, Seed B: RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1–initiated apoptosis. EMBO J 15: 6189–6196, 1996Google Scholar
  148. 148.
    Heller RA, Song K, Fan N, Chang DJ: The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70: 47–56, 1992Google Scholar
  149. 149.
    Haridas V, Darnay BG, Natarajan K, Heller R, Aggarwal BB: Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol 160: 3152–3162, 1998Google Scholar
  150. 150.
    Memon SA, Hou J, Moreno MB, Zacharchuk CM: Apoptosis induced by a chimeric Fas/FLICE receptor: Lack of requirement for Fas-or FADD-binding proteins. J Immunol 160: 2046–2049, 1998Google Scholar
  151. 151.
    Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S, Rojas L, Aggarwal BB, Ruben S, Li LY, Gentz R, Yu GL: VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J 13: 181–189, 1999Google Scholar
  152. 152.
    Haridas V, Shrivastava A, Su J, Yu GL, Ni J, Liu D, Chen SF, Ni Y, Ruben SM, Gentz R, Aggarwal BB: VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncogene 18(47):6496–6504, 1999Google Scholar
  153. 153.
    Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673–682, 1995Google Scholar
  154. 154.
    Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A: Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12(6):611–620, 2000Google Scholar
  155. 155.
    Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV: Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Oncogene 20: 7965–7975, 2001Google Scholar
  156. 156.
    Bridgham JT, Bobe J, Goetz FW, Johnson AL: Conservation of death receptor-6 in avian and piscine vertebrates. Biochem Biophys Res Commun 284: 1109–1115, 1995Google Scholar
  157. 157.
    Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798–802, 1993Google Scholar
  158. 158.
    Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N: Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192: 1809–1818, 2000Google Scholar
  159. 159.
    Mukhopadhyay A, Suttles J, Stout RD, Aggarwal BB: Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages. J Biol Chem 276: 31906–31912, 2001Google Scholar
  160. 160.
    Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D: Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol 167: 1592–1600, 2001Google Scholar
  161. 161.
    Jacobson BA, Panka DJ, Nguyen KA, Erikson J, Abbas AK, Marshak-Rothstein A: Anatomy of autoantibody production: Dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3: 509–519, 1995Google Scholar
  162. 162.
    Singer GG, Abbas AK: The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365–371, 1994Google Scholar
  163. 163.
    Wang EC, Thern A, Denzel A, Kitson J, Farrow SN, Owen MJ: DR3 regulates negative selection during thymocyte development. Mol Cell Biol 21: 3451–3461, 2001Google Scholar
  164. 164.
    Ozoren N, Fisher MJ, Kim K, Liu CX, Genin A, Shifman Y, Dicker DT, Spinner NB, Lisitsyn NA, El-Deiry WS: Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 16: 917–925, 2000Google Scholar
  165. 165.
    Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD, Na S: Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med 197: 51–62, 2003Google Scholar
  166. 166.
    Liu J, Na S, Glasebrook A, Fox N, Solenberg PJ, Zhang Q, Song HY, Yang DD: Enhanced CD4+ T cell proliferation and Th2 cytokine production in DR6–deficient mice. Immunity 15: 23–34, 2001Google Scholar
  167. 167.
    Zhao H, Yan M, Wang H, Erickson S, Grewal IS, Dixit VM: Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6–deficient mice. J Exp Med 194: 1441–1448, 2001Google Scholar
  168. 168.
    Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD, Na S: Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med 197: 51–62, 2003Google Scholar
  169. 169.
    Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699–703, 1998Google Scholar
  170. 170.
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, Sander S, Van G, Tarpley J, Derby P, Lee R: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309–319, 1997Google Scholar
  171. 171.
    White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H: Genetic control of programmed cell death in Drosophila. Science 264: 677–683, 1994Google Scholar
  172. 172.
    Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961–4965, 1996Google Scholar
  173. 173.
    Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong YY, Ohashi PS, Choi Y: A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185: 1777–1783, 1997Google Scholar
  174. 174.
    Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6, 1994Google Scholar
  175. 175.
    Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ: Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69: 597–604, 1992Google Scholar
  176. 176.
    Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914–6925, 1997Google Scholar
  177. 177.
    Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517–521, 1997Google Scholar
  178. 178.
    Tschopp J, Irmler M, Thome M: Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10: 552–558, 1998Google Scholar
  179. 179.
    Irisarri M, Plumas J, Bonnefoix T, Jacob MC, Roucard C, Pasquier MA, Sotto JJ, Lajmanovich A: Resistance to CD95–mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line. Leukemia 14: 2149–2158, 2000Google Scholar
  180. 180.
    Kirchhoff S, Muller WW, Krueger A, Schmitz I, Krammer PH: TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95–mediated apoptosis by blocking death-inducing signaling complex activity. J Immunol 165: 6293–6300, 2000Google Scholar
  181. 181.
    Yoshikawa H, Nakajima Y, Tasaka K: Enhanced expression of Fas-associated death domain-like IL-1–converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J Immunol 165:6262–6269, 2000Google Scholar
  182. 182.
    Hennino A, Berard M, Krammer PH, Defrance T: FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J Exp Med 193: 447–458, 2001Google Scholar
  183. 183.
    Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW: Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12(6):633–642, 2000Google Scholar
  184. 184.
    Miki K, Eddy EM: Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain. Mol Cell Biol 22(8):2536–2543, 2002Google Scholar
  185. 185.
    Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580–584, 1998Google Scholar
  186. 186.
    Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917–921, 1997Google Scholar
  187. 187.
    Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET: Protection against Fas/APO-1–and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 157(10):4277–4281, 1996Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  1. 1.Cytokine Research Laboratory, Department of BioimmunotherapyThe University of Texas M. D. Anderson Cancer CenterHouston

Personalised recommendations